The Challenge
This top-20 global pharmaceutical company was managing 12 concurrent clinical trials across more than 200 sites worldwide. Their technology landscape had grown organically over years, resulting in separate systems for EDC, eTMF, and CTMS that didn't communicate with each other.
The data silos were causing massive inefficiencies. Reconciling data between their EDC and eTMF systems alone took an average of 3 weeks per reconciliation cycle. Clinical operations staff spent more time copying data between systems than analyzing it.
Site staff bore the brunt of the complexity. Coordinators and investigators had to maintain credentials for 5 different portals, each with different interfaces and workflows. The frustration was driving down site satisfaction scores and, critically, affecting enrollment timelines as sites deprioritized their studies.
For the first time, we have real-time visibility across every site and every trial. The data just flows.
Head of Clinical Data Management
The Solution
The company deployed Clincove as a unified operational layer sitting atop their existing CTMS investment. Rather than a rip-and-replace approach, Clincove's API integration connected seamlessly with their enterprise CTMS, preserving existing workflows while eliminating data silos.
For site staff, the transformation was immediate. A single sign-on gave them access to all trial-related activities: data entry, document management, communication, and visit tracking. No more juggling five different portals.
The clinical operations team gained real-time dashboards showing enrollment status, data quality metrics, and document completeness across all 200+ sites. What previously required weeks of manual data pulls and spreadsheet reconciliation was now available at a glance.
The Results
The 80% reduction in data reconciliation time was the headline metric, but the ripple effects were equally significant. With real-time data flow, the company could identify enrollment bottlenecks and data quality issues in days instead of weeks.
The 94% site adoption rate within the first month was unprecedented for a technology rollout of this scale. Sites reported that Clincove's unified interface was intuitive enough that many coordinators needed minimal training beyond the initial orientation.
The $2.4 million in annual operational savings came from reduced headcount dedicated to data reconciliation, elimination of redundant vendor contracts, and fewer protocol deviations caught earlier in the process.
What's Next
The company is now expanding Clincove to all new trial starts and planning a migration of their remaining legacy trials. They are also piloting Clincove's Protocol AI capabilities to automate CRF generation and are exploring risk-based monitoring powered by the platform's real-time analytics.